Rate and predictors of successful antitumor necrosis factor deescalation after dose intensification in inflammatory bowel disease patients: a real-world Greek–Turkish collaborative study

Viazis, Nikos; Törüner, Murat; Papastergiou, Vasilios; Mousourakis, Konstantinos; Christidou, Angeliki; Tzouvala, Maria; Zacharopoulou, Eirini; Palatianou, Maria; Theocharis, Georgios; Geramoutsos, Georgios; Theodoropoulou, Anǵeliki; Κarmiris, Konstantinos; Velegraki, Magdalini; Ferhat Çelık, Aykut; Akpınar, Atilla; Zampeli, Evanthia; Papathanasiou, Evgenia; Gülşen Ünal, Nalan; Kapsoritakis, Andreas; Argyriou, Konstantinos; Christodoulou, Dimitrios; Κατσάνος, Κωνσταντίνος; S. Fousekis, Fotios; Karakan, Tarkan; E. Κoutroubakis, Ioannis; Drygiannakis, Ioannis; Γιουλεμέ, Όλγα; Kalogirou, Maria; Vlachou, Evangelina; Liatsos, Christos; Kyriakos, Nikolaos; Tsironi, Eftychia; Markopoulos, Panagiotis; Bamias, George; Chalakatevaki, K; Tsiolakidou, Georgia; Lamouri, Charikleia; Tribonias, George; Dimopoulou, Konstantina; Kasapidis, Panagiotis; Paraskeva, Konstantina; Telli, Pelin; Akyüz, Filiz

doi:10.1097/meg.0000000000003083

Public

Rate and predictors of successful antitumor necrosis factor deescalation after dose intensification in inflammatory bowel disease patients: a real-world Greek–Turkish collaborative study

Published in European Journal of Gastroenterology & Hepatology • Nov 26, 2025

Authors:

Nikos Viazis

Murat Törüner

Vasilios Papastergiou

Abstract

OBJECTIVES: To identify the rate and predictors of successful antitumor necrosis factor (TNF) dose deescalation in patients with inflammatory bowel disease (IBD). METHODS: This multicenter retrospective cohort study collected data from consecutive IBD patients followed at referral centers in Greece ...

Subject

Medicine

Inflammatory bowel disease

Internal medicine

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!